JezK

Edit File: 1608706056.M846985P2359294.mocha3025.mochahost.com,S=26147,W=26607:2,S

Envelope-to: quraishi@jack.ngo
Delivery-date: Wed, 23 Dec 2020 01:47:36 -0500
From: Shabnam Baheej <shabnam.baheej@unwomen.org>
To: Shabnam Baheej <shabnam.baheej@unwomen.org>
CC: Zahra HOSSAINY <zahra.hossainy@unwomen.org>, Vicki Aken
	<Vicki.Aken@rescue.org>, Geeta Kuttiparambil
	<geeta.kuttiparambil@unwomen.org>, Zuhra Wardak <Zuhra.Wardak@rescue.org>,
	Marzia Rezai MEDICA <marzia.rezai@medica-afghanistan.org>
Subject: FW: CVA & GBV Compendium training modules
Thread-Topic: CVA & GBV Compendium training modules
Thread-Index: AdbYS/xREsFidcuxQOCyWE8aOFsZqAAoeq/wAAD2xG4AAF2PEA==
Date: Wed, 23 Dec 2020 06:46:27 +0000
Message-ID:
 <DM6PR07MB4362E6A3A586FCBD5A9FFA489EDE0@DM6PR07MB4362.namprd07.prod.outlook.com>
References:
 <AM0PR07MB398823B288DA8C948086F811FDDF0@AM0PR07MB3988.eurprd07.prod.outlook.com>,<BY5PR12MB43238534B75CD2D02D621FFAE8DE0@BY5PR12MB4323.namprd12.prod.outlook.com>
 <BN7PR07MB4850A2C4476F0681B91F1E199DDE0@BN7PR07MB4850.namprd07.prod.outlook.com>
In-Reply-To:
 <BN7PR07MB4850A2C4476F0681B91F1E199DDE0@BN7PR07MB4850.namprd07.prod.outlook.com>
Accept-Language: en-US
Content-Language: en-US
Content-Type: multipart/alternative;
	boundary="_000_DM6PR07MB4362E6A3A586FCBD5A9FFA489EDE0DM6PR07MB4362namp_"
MIME-Version: 1.0
X-MS-Exchange-CrossTenant-Network-Message-Id: 7554fd4f-6fa4-4643-42e4-08d8a70e7967
X-MS-Exchange-CrossTenant-originalarrivaltime: 23 Dec 2020 06:46:27.5369
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 2bcd0744-9e18-487d-85c3-c9a325220be8
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: cwo34QIH2KYgo+qxnhclu/00Y9eBckoTxbyc6BONyAqvbD9g+yn5Ch/3SznHOqkrppdduPn9pzjBbr4NZYuHCbV/wmIIOM4iJDCHiRoQ5YY=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DM6PR07MB5739
X-Spam-Status: No, score=-0.2
X-Spam-Score: -1
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "mocha3025.mochahost.com",
 has NOT identified this incoming email as spam. The original
 message has been attached to this so you can view it or label
 similar future email. If you have any questions, see
 root\@localhost for details.
 Content preview: ***Apologies for cross-posting*** Dear GiHA Working Group
 members, Please find the below links for GBV Risks and Benefits Analysis Tool
 for VCA in English plus Dari and Pashto translations shared by CARE, for
 your reference. For further details, kindly check the belo [...] 
 Content analysis details: (-0.2 points, 5.0 required)
 pts rule name description
 ---- ---------------------- --------------------------------------------------
 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
 blocked. See
 http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
 for more information.
 [URIs: proofpoint.com]
 -0.0 RCVD_IN_MSPIKE_H2 RBL: Average reputation (+2)
 [40.107.93.71 listed in wl.mailspike.net]
 -0.0 SPF_PASS SPF: sender matches SPF record
 -0.0 SPF_HELO_PASS SPF: HELO matches SPF record
 0.0 HTML_MESSAGE BODY: HTML included in message
 -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
 author's domain
 -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
 -0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
 envelope-from domain
 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
 valid
X-Spam-Flag: NO

--_000_DM6PR07MB4362E6A3A586FCBD5A9FFA489EDE0DM6PR07MB4362namp_
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

***Apologies for cross-posting***

Dear GiHA Working Group members,

Please find the below links for GBV Risks and Benefits Analysis Tool for VC=
A in English plus Dari and Pashto translations shared by CARE, for your ref=
erence.
For further details, kindly check the below email.

With best regards,
Shabnam
--

Dear Colleagues,

CARE has taken the lead to translate the GBV Risks and Benefits Analysis To=
ol for CVA  into many languages including Dari and Pashto and is in editabl=
e format for easy uptake. This tool goes with the CVA & GBV Compendium and =
is referenced within the associated training package too.

GBV Risk and Benefit Analysis Tool for CVA in Editable Format (English)<htt=
ps://nam10.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Furldefense=
.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__eur03.safelinks.protection.outlo=
ok.com_-3Furl-3Dhttps-253A-252F-252Fs33660.pcdn.co-252Fwp-2Dcontent-252Fupl=
oads-252F2018-252F02-252FEnglish.zip-26data-3D04-257C01-257Cabandokht.sarka=
rati-2540drc.ngo-257Ced68ebaff4fd4e1d5db208d8a66045bf-257C2a212241899c4752b=
d3351eac3c582d5-257C0-257C0-257C637442279743932322-257CUnknown-257CTWFpbGZs=
b3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-253D-25=
7C3000-26sdata-3DZa5cArgQZkYeWsqP4AONfNd9aQ5rDzrKThXiCsiF22Y-253D-26reserve=
d-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm2He4OdaqbWh55g%26r%3DuLYfwzvN-NUUlBsUJT3a_=
64sLNh9yR67i5xruateN1c%26m%3DKUW8zL7OaC0anO0Mb6D_iwZsTxmxBfDXnPecXF6pAdw%26=
s%3Dp_eABsBzrVg2fyYlOXML7AilvVJoRVLQhGGwY9-ixr4%26e%3D&data=3D04%7C01%7Csha=
bnam.baheej%40unwomen.org%7Cb24dcb3be1664c27dbaf08d8a7091c52%7C2bcd07449e18=
487d85c3c9a325220be8%7C0%7C0%7C637443004860572701%7CUnknown%7CTWFpbGZsb3d8e=
yJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sd=
ata=3DMqg2AJ9ZxRsmWYrBTTodVUwYfXnlX29f12YJXPQpT0Q%3D&reserved=3D0>

GBV Risk and Benefit Analysis Tool for CVA Editable Format (Dari)<https://n=
am10.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Furldefense.proof=
point.com%2Fv2%2Furl%3Fu%3Dhttps-3A__eur03.safelinks.protection.outlook.com=
_-3Furl-3Dhttps-253A-252F-252Fs33660.pcdn.co-252Fwp-2Dcontent-252Fuploads-2=
52F2018-252F02-252FTemplate-5FGBV-5FRisk-5FAnalysis-5Ffor-5FCVA-5FDari.pdf-=
26data-3D04-257C01-257Cabandokht.sarkarati-2540drc.ngo-257Ced68ebaff4fd4e1d=
5db208d8a66045bf-257C2a212241899c4752bd3351eac3c582d5-257C0-257C0-257C63744=
2279743952303-257CUnknown-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luM=
zIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-253D-257C3000-26sdata-3DIQ-252FyE6gRUEs9JhVm=
BY-252Fk9d27X0AaAqTKfNIFstDGMzk-253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3n=
QZwm2He4OdaqbWh55g%26r%3DuLYfwzvN-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3D=
KUW8zL7OaC0anO0Mb6D_iwZsTxmxBfDXnPecXF6pAdw%26s%3DCzHVAF7jZOb87Nmnsr4g5_Uau=
L63EzFvs_f7-n3e4Ow%26e%3D&data=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb=
24dcb3be1664c27dbaf08d8a7091c52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%=
7C637443004860582705%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2=
luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3D1YaLQWDDpe4Is0epGBqAgfw=
WpZxkFX9mdJY4B0sfVVM%3D&reserved=3D0>

GBV Risk and Benefit Analysis Tool for CVA Editable Format (Pashto)<https:/=
/nam10.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2Furldefense.pro=
ofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__eur03.safelinks.protection.outlook.c=
om_-3Furl-3Dhttps-253A-252F-252Fs33660.pcdn.co-252Fwp-2Dcontent-252Fuploads=
-252F2018-252F02-252FTemplate-5FGBV-5FRisk-5FAnalysis-5Ffor-5FCVA-5FPashto.=
pdf-26data-3D04-257C01-257Cabandokht.sarkarati-2540drc.ngo-257Ced68ebaff4fd=
4e1d5db208d8a66045bf-257C2a212241899c4752bd3351eac3c582d5-257C0-257C0-257C6=
37442279743962299-257CUnknown-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV=
2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-253D-257C3000-26sdata-3DJ2yJoXlE2ObFleFY=
mR1i614hfsY81-252F33W6HXKNpmGNc-253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3n=
QZwm2He4OdaqbWh55g%26r%3DuLYfwzvN-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3D=
KUW8zL7OaC0anO0Mb6D_iwZsTxmxBfDXnPecXF6pAdw%26s%3D1SfIYzEw0BpdfETY1191qkR1l=
5CGQ-tWsIM239VXyb4%26e%3D&data=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb=
24dcb3be1664c27dbaf08d8a7091c52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%=
7C637443004860592697%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2=
luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=3DOHB3oslFhkXowI3LuvQQ1De=
MbUuA4VPmdBig51c2EKA%3D&reserved=3D0>

The Compendium, the training package and other key resources are available =
here:

Resources for Mainstreaming Gender-Based Violence (GBV) Considerations in C=
ash and Voucher Assistance (CVA) and Utilizing CVA in GBV Prevention and Re=
sponse<https://nam10.safelinks.protection.outlook.com/?url=3Dhttps%3A%2F%2F=
urldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__eur03.safelinks.protec=
tion.outlook.com_-3Furl-3Dhttps-253A-252F-252Fwww.womensrefugeecommission.o=
rg-252Fresearch-2Dresources-252Fmainstreaming-2Dgender-2Dbased-2Dviolence-2=
Dconsiderations-2Dcash-2Dvoucher-2Dassistance-252F-26data-3D04-257C01-257Ca=
bandokht.sarkarati-2540drc.ngo-257Ced68ebaff4fd4e1d5db208d8a66045bf-257C2a2=
12241899c4752bd3351eac3c582d5-257C0-257C0-257C637442279743972291-257CUnknow=
n-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXV=
CI6Mn0-253D-257C3000-26sdata-3DE3QEr0A9YKoN2RbmJWAFczH8W43R6i2KHzRUqBQNZaE-=
253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm2He4OdaqbWh55g%26r%3DuLYfwzv=
N-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3DKUW8zL7OaC0anO0Mb6D_iwZsTxmxBfDX=
nPecXF6pAdw%26s%3DLoQexYBdVi2fFBDEZxAT-FunGss8CqW7nD5m3xCfJeE%26e%3D&data=
=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb24dcb3be1664c27dbaf08d8a7091c5=
2%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%7C637443004860602690%7CUnknown=
%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6=
Mn0%3D%7C1000&sdata=3D2%2B7%2BJUgq5ABZrDWrIfDEYV8t4FRTdv2vWhmzoYwsmFo%3D&re=
served=3D0>

Best,

Abandokht

--_000_DM6PR07MB4362E6A3A586FCBD5A9FFA489EDE0DM6PR07MB4362namp_
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" xmlns:o=3D"urn:schemas-micr=
osoft-com:office:office" xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" xmlns=3D"http:=
//www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dus-ascii"=
>
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered medium)">
<style></style>
</head>
<body lang=3D"EN-US" link=3D"#0563C1" vlink=3D"purple" style=3D"word-wrap:b=
reak-word">
<div class=3D"WordSection1">
<div>
<div>
***Apologies for cross-posting*** <o:p></o:p>
<o:p>&nbsp;</o:p>
Dear GiHA Working Group members,<o:p></o:p>
<o:p>&nbsp;</o:p>
Please find the below links for GBV Risks and Ben=
efits Analysis Tool for VCA in English plus Dari and Pashto translation=
s shared by CARE, for your reference.
<o:p></o:p>
For further details, kindly check the below email. <=
o:p></o:p>
<o:p>&nbsp;</o:p>
With best regards, <o:p></o:p>
Shabnam<o:p></o:p>
--<o:p></o:p>
&nbsp;<o:p></o:p>
<o:p>&nbsp;</o:p>
Dear Colleagues,=
<o:p></o:p>
&nbsp;<o:p></o:p=
>
CARE has taken the lead=
 to translate the
GBV Risks and Benefits Analysis Tool for CVA&nbsp; into many languag=
es including Dari and Pashto and is in editable format for easy uptake. Thi=
s tool goes with the CVA &amp; GBV Compendium and is referenced within the =
associated training package too.&nbsp;<o:p></o:p>
&nbsp;=
<o:p></o:p>
<a href=3D"https://nam10.safelinks.protection.outlo=
ok.com/?url=3Dhttps%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp=
s-3A__eur03.safelinks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Fs=
33660.pcdn.co-252Fwp-2Dcontent-252Fuploads-252F2018-252F02-252FEnglish.zip-=
26data-3D04-257C01-257Cabandokht.sarkarati-2540drc.ngo-257Ced68ebaff4fd4e1d=
5db208d8a66045bf-257C2a212241899c4752bd3351eac3c582d5-257C0-257C0-257C63744=
2279743932322-257CUnknown-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luM=
zIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-253D-257C3000-26sdata-3DZa5cArgQZkYeWsqP4AON=
fNd9aQ5rDzrKThXiCsiF22Y-253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm2He4=
OdaqbWh55g%26r%3DuLYfwzvN-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3DKUW8zL7O=
aC0anO0Mb6D_iwZsTxmxBfDXnPecXF6pAdw%26s%3Dp_eABsBzrVg2fyYlOXML7AilvVJoRVLQh=
GGwY9-ixr4%26e%3D&amp;data=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb24dc=
b3be1664c27dbaf08d8a7091c52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%7C63=
7443004860572701%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMz=
IiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=3DMqg2AJ9ZxRsmWYrBTTodVUw=
YfXnlX29f12YJXPQpT0Q%3D&amp;reserved=3D0" target=3D"_blank">GBV
 Risk and Benefit Analysis Tool for CVA in Editable Format (English)=
</a><o:p></o:p>
&nbsp;<o:p></o:p>
<a href=3D"https://nam10.safelinks.protection.outlo=
ok.com/?url=3Dhttps%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp=
s-3A__eur03.safelinks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Fs=
33660.pcdn.co-252Fwp-2Dcontent-252Fuploads-252F2018-252F02-252FTemplate-5FG=
BV-5FRisk-5FAnalysis-5Ffor-5FCVA-5FDari.pdf-26data-3D04-257C01-257Cabandokh=
t.sarkarati-2540drc.ngo-257Ced68ebaff4fd4e1d5db208d8a66045bf-257C2a21224189=
9c4752bd3351eac3c582d5-257C0-257C0-257C637442279743952303-257CUnknown-257CT=
WFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-=
253D-257C3000-26sdata-3DIQ-252FyE6gRUEs9JhVmBY-252Fk9d27X0AaAqTKfNIFstDGMzk=
-253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm2He4OdaqbWh55g%26r%3DuLYfwz=
vN-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3DKUW8zL7OaC0anO0Mb6D_iwZsTxmxBfD=
XnPecXF6pAdw%26s%3DCzHVAF7jZOb87Nmnsr4g5_UauL63EzFvs_f7-n3e4Ow%26e%3D&amp;d=
ata=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb24dcb3be1664c27dbaf08d8a709=
1c52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%7C637443004860582705%7CUnkn=
own%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXV=
CI6Mn0%3D%7C1000&amp;sdata=3D1YaLQWDDpe4Is0epGBqAgfwWpZxkFX9mdJY4B0sfVVM%3D=
&amp;reserved=3D0" target=3D"_blank">GBV
 Risk and Benefit Analysis Tool for CVA Editable Format (Dari)</span=
></a><o:p></o:p>
&nbsp;<o:p></o:p>
<a href=3D"https://nam10.safelinks.protection.outlo=
ok.com/?url=3Dhttps%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp=
s-3A__eur03.safelinks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Fs=
33660.pcdn.co-252Fwp-2Dcontent-252Fuploads-252F2018-252F02-252FTemplate-5FG=
BV-5FRisk-5FAnalysis-5Ffor-5FCVA-5FPashto.pdf-26data-3D04-257C01-257Cabando=
kht.sarkarati-2540drc.ngo-257Ced68ebaff4fd4e1d5db208d8a66045bf-257C2a212241=
899c4752bd3351eac3c582d5-257C0-257C0-257C637442279743962299-257CUnknown-257=
CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn=
0-253D-257C3000-26sdata-3DJ2yJoXlE2ObFleFYmR1i614hfsY81-252F33W6HXKNpmGNc-2=
53D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm2He4OdaqbWh55g%26r%3DuLYfwzvN=
-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3DKUW8zL7OaC0anO0Mb6D_iwZsTxmxBfDXn=
PecXF6pAdw%26s%3D1SfIYzEw0BpdfETY1191qkR1l5CGQ-tWsIM239VXyb4%26e%3D&amp;dat=
a=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb24dcb3be1664c27dbaf08d8a7091c=
52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%7C637443004860592697%7CUnknow=
n%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI=
6Mn0%3D%7C1000&amp;sdata=3DOHB3oslFhkXowI3LuvQQ1DeMbUuA4VPmdBig51c2EKA%3D&a=
mp;reserved=3D0" target=3D"_blank">GBV
 Risk and Benefit Analysis Tool for CVA Editable Format (Pashto)</sp=
an></a><o:p></o:p>
&nbsp;<o:p></o:p>
&nbsp;<o:p></o:p>
The Co=
mpendium, the training package and other key resources are available here:<=
/span><o:p></o:p>
&nbsp;=
<o:p></o:p>
<a href=3D"https://nam10.safelinks.protection.outlo=
ok.com/?url=3Dhttps%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp=
s-3A__eur03.safelinks.protection.outlook.com_-3Furl-3Dhttps-253A-252F-252Fw=
ww.womensrefugeecommission.org-252Fresearch-2Dresources-252Fmainstreaming-2=
Dgender-2Dbased-2Dviolence-2Dconsiderations-2Dcash-2Dvoucher-2Dassistance-2=
52F-26data-3D04-257C01-257Cabandokht.sarkarati-2540drc.ngo-257Ced68ebaff4fd=
4e1d5db208d8a66045bf-257C2a212241899c4752bd3351eac3c582d5-257C0-257C0-257C6=
37442279743972291-257CUnknown-257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV=
2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0-253D-257C3000-26sdata-3DE3QEr0A9YKoN2Rbm=
JWAFczH8W43R6i2KHzRUqBQNZaE-253D-26reserved-3D0%26d%3DDwMFAg%26c%3D0u3nQZwm=
2He4OdaqbWh55g%26r%3DuLYfwzvN-NUUlBsUJT3a_64sLNh9yR67i5xruateN1c%26m%3DKUW8=
zL7OaC0anO0Mb6D_iwZsTxmxBfDXnPecXF6pAdw%26s%3DLoQexYBdVi2fFBDEZxAT-FunGss8C=
qW7nD5m3xCfJeE%26e%3D&amp;data=3D04%7C01%7Cshabnam.baheej%40unwomen.org%7Cb=
24dcb3be1664c27dbaf08d8a7091c52%7C2bcd07449e18487d85c3c9a325220be8%7C0%7C0%=
7C637443004860602690%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2=
luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=3D2%2B7%2BJUgq5ABZrDW=
rIfDEYV8t4FRTdv2vWhmzoYwsmFo%3D&amp;reserved=3D0">Resources
 for Mainstreaming Gender-Based Violence (GBV) Considerations in Cash and V=
oucher Assistance (CVA) and Utilizing CVA in GBV Prevention and Response</s=
pan></a><o:p></o:p>
&nbsp;=
<o:p></o:p>
Best,<=
/span><o:p></o:p>
Abando=
kht 
<o:p></o:p>
</div>
</div>
</div>
</body>
</html>

--_000_DM6PR07MB4362E6A3A586FCBD5A9FFA489EDE0DM6PR07MB4362namp_--